To lead the industry in the promising domain of in vitro diagnostics for the early detection of cancer, coronaviruses and neurodegenerative disorders by developing novel blood tests that are reliable, affordable and minimally invasive. The easy implementation and cost effectiveness of blood-based testing, as an additional diagnostic layer, greatly expands early screening participation.Our proprietary TBIA platform employs peri...
To lead the industry in the promising domain of in vitro diagnostics for the early detection of cancer, coronaviruses and neurodegenerative disorders by developing novel blood tests that are reliable, affordable and minimally invasive. The easy implementation and cost effectiveness of blood-based testing, as an additional diagnostic layer, greatly expands early screening participation.Our proprietary TBIA platform employs peripheral blood spectroscopy analysis to observe immune response to tumor presence.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.